Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for GH

Stock Name	Guardant Health Inc
Ticker	GH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US40131M1099
LEI	254900M8C3E5VC8BR186

Show aggregate GH holdings

News associated with GH

GH Crosses Above Average Analyst Target: In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $59.43, changing hands for $60.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va - 2025-08-15 09:41:48
Deutsche Bank AG Sells 30,534 Shares of Guardant Health, Inc. (NASDAQ:GH): Deutsche Bank AG cut its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The fund owned 746,636 shares of the company’s stock after selling 30,534 shares during the period. Deutsche Bank AG’s holdings in Guardant Health were worth $31,807,000 as of its most […] - 2025-08-13 05:19:03
XTX Topco Ltd Sells 26,522 Shares of Guardant Health, Inc. (NASDAQ:GH): XTX Topco Ltd cut its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 84.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,935 shares of the company’s stock after selling 26,522 shares during the quarter. XTX […] - 2025-08-13 04:28:44
Brokerages Set Guardant Health, Inc. (NASDAQ:GH) PT at $54.45: Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has received a consensus rating of “Buy” from the twenty ratings firms that are covering the stock, Marketbeat.com reports. Nineteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price target […] - 2025-08-01 03:08:57
Guardant Health (GH) Q2 Revenue Up 31%: Key PointsRevenue soared 31% year over year to $232.1 million in Q2 2025, beating analyst estimates by $20.6 million for Q2 2025. - 2025-07-31 06:06:40
KLP Kapitalforvaltning AS Has $1 Million Holdings in Guardant Health, Inc. (NASDAQ:GH): KLP Kapitalforvaltning AS cut its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 5.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,500 shares of the company’s stock after selling 1,300 shares during the period. KLP Kapitalforvaltning […] - 2025-07-29 05:28:52
Guardant Health, Inc. (NASDAQ:GH) Stake Boosted by New York State Common Retirement Fund: New York State Common Retirement Fund grew its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 184.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 106,884 shares of the company’s stock after purchasing an additional 69,257 shares during […] - 2025-07-22 07:10:51
SBI Securities Co. Ltd. Lowers Stock Holdings in Guardant Health, Inc. (NASDAQ:GH): SBI Securities Co. Ltd. reduced its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 51.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 685 shares of the company’s stock after selling 730 shares during the period. SBI Securities Co. Ltd.’s holdings in Guardant Health were […] - 2025-07-21 05:22:55
Edgestream Partners L.P. Buys New Shares in Guardant Health, Inc. (NASDAQ:GH): Edgestream Partners L.P. bought a new stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor bought 20,425 shares of the company’s stock, valued at approximately $870,000. Several other large investors have also recently bought and sold shares of GH. Raymond James Financial Inc. acquired […] - 2025-07-20 06:02:53
Analysts Anticipate FMDE Will Reach $38: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-17 10:38:36
Gamehost (TSE:GH) Hits New 12-Month High Following Dividend Announcement: Gamehost Inc. (TSE:GH – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday following a dividend announcement from the company. The company traded as high as C$12.28 and last traded at C$12.28, with a volume of 3378 shares trading hands. The stock had previously closed at C$12.14. The newly announced […] - 2025-07-02 02:26:54
Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells $322,791.36 in Stock: Guardant Health, Inc. (NASDAQ:GH – Get Free Report) Director Ian T. Clark sold 6,672 shares of the business’s stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $48.38, for a total value of $322,791.36. Following the completion of the sale, the director now owns 9,851 […] - 2025-06-23 05:24:54
Fifth Third Bancorp Acquires New Holdings in Guardant Health, Inc. (NASDAQ:GH): Fifth Third Bancorp acquired a new position in Guardant Health, Inc. (NASDAQ:GH – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 6,560 shares of the company’s stock, valued at approximately $279,000. A number of other hedge funds […] - 2025-06-19 05:05:05
Guardant Health (NASDAQ:GH) Given New $65.00 Price Target at Mizuho: Guardant Health (NASDAQ:GH – Free Report) had its price target raised by Mizuho from $60.00 to $65.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also recently weighed in on the company. Raymond James reiterated an […] - 2025-06-16 02:50:49
Rhumbline Advisers Buys 8,202 Shares of Guardant Health, Inc. (NASDAQ:GH): Rhumbline Advisers boosted its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 4.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 175,432 shares of the company’s stock after buying an additional 8,202 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-06-12 05:08:52
Amirali Talasaz Sells 39,751 Shares of Guardant Health, Inc. (NASDAQ:GH) Stock: Guardant Health, Inc. (NASDAQ:GH – Get Free Report) CEO Amirali Talasaz sold 39,751 shares of the business’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $50.07, for a total value of $1,990,332.57. Following the completion of the sale, the chief executive officer now directly […] - 2025-06-11 05:19:04
Amirali Talasaz Sells 77,853 Shares of Guardant Health, Inc. (NASDAQ:GH) Stock: Guardant Health, Inc. (NASDAQ:GH – Get Free Report) CEO Amirali Talasaz sold 77,853 shares of the stock in a transaction that occurred on Monday, June 9th. The stock was sold at an average price of $50.09, for a total value of $3,899,656.77. Following the transaction, the chief executive officer now owns 2,069,456 shares in the […] - 2025-06-11 05:18:57
GAMMA Investing LLC Raises Position in Guardant Health, Inc. (NASDAQ:GH): GAMMA Investing LLC increased its holdings in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 11,765.1% during the first quarter, HoldingsChannel reports. The institutional investor owned 17,679 shares of the company’s stock after acquiring an additional 17,530 shares during the quarter. GAMMA Investing LLC’s holdings in Guardant Health were worth $7,530,000 at the end of […] - 2025-06-09 05:12:48
California State Teachers Retirement System Sells 749 Shares of Guardant Health, Inc. (NASDAQ:GH): California State Teachers Retirement System trimmed its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 0.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,687 shares of the company’s stock after selling 749 shares during the period. California State Teachers […] - 2025-06-05 05:28:52
Guardant Health, Inc. (NASDAQ:GH) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 4.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,180 shares of the company’s stock after acquiring an additional 2,562 […] - 2025-05-22 07:41:08
Janus Henderson Group PLC Sells 3,900 Shares of Guardant Health, Inc. (NASDAQ:GH): Janus Henderson Group PLC trimmed its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 6.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 56,678 shares of the company’s stock after selling 3,900 shares during the […] - 2025-05-22 06:48:59
Focus Partners Wealth Buys Shares of 17,896 Guardant Health, Inc. (NASDAQ:GH): Focus Partners Wealth bought a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 17,896 shares of the company’s stock, valued at approximately $547,000. Several other large investors also recently […] - 2025-05-20 05:22:57
Analysts See 11% Upside For The Holdings of FTQI: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-13 08:43:46
Stifel Financial Corp Grows Stock Holdings in Guardant Health, Inc. (NASDAQ:GH): Stifel Financial Corp lifted its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 25.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 49,927 shares of the company’s stock after purchasing an additional 10,006 shares during the period. Stifel Financial Corp’s holdings in Guardant Health were worth $1,525,000 at the end […] - 2025-05-07 05:38:58
Guardant Health, Inc. (NASDAQ:GH) Stock Holdings Raised by Hsbc Holdings PLC: Hsbc Holdings PLC lifted its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 25.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,011 shares of the company’s stock after purchasing an additional 3,863 shares during the period. Hsbc Holdings PLC’s holdings […] - 2025-05-07 05:00:50
First Trust Advisors LP Sells 50,951 Shares of Guardant Health, Inc. (NASDAQ:GH): First Trust Advisors LP cut its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 47.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,723 shares of the company’s stock after selling 50,951 shares during the quarter. First […] - 2025-05-06 05:41:07
Raymond James Financial Inc. Buys Shares of 72,364 Guardant Health, Inc. (NASDAQ:GH): Raymond James Financial Inc. purchased a new stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 72,364 shares of the company’s stock, valued at approximately $2,211,000. Raymond James Financial Inc. […] - 2025-05-01 06:18:47
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Marshall Wace LLP: Marshall Wace LLP trimmed its holdings in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 99.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,085 shares of the company’s stock after selling 17,717,915 shares during the quarter. Marshall Wace LLP’s holdings in Guardant […] - 2025-05-01 05:42:53
8,118 Shares in Guardant Health, Inc. (NASDAQ:GH) Acquired by Bank of Montreal Can: Bank of Montreal Can acquired a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) during the 4th quarter, HoldingsChannel reports. The firm acquired 8,118 shares of the company’s stock, valued at approximately $248,000. Several other institutional investors and hedge funds have also bought and sold shares of GH. Arizona State Retirement System boosted […] - 2025-04-25 06:14:43
Rockefeller Capital Management L.P. Boosts Position in Guardant Health, Inc. (NASDAQ:GH): Rockefeller Capital Management L.P. lifted its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 20.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,357 shares of the company’s stock after purchasing an additional 2,757 shares during the period. Rockefeller Capital Management L.P.’s holdings […] - 2025-04-24 06:00:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) GH holdings

Date	Number of GH Shares Held	Base Market Value of GH Shares	Local Market Value of GH Shares	Change in GH Shares Held	Change in GH Base Value	Current Price per GH Share Held	Previous Price per GH Share Held
2025-12-03 (Wednesday)	87,815	USD 9,304,877	USD 9,304,877	0	USD 183,533	USD 105.96	USD 103.87
2025-12-02 (Tuesday)	87,815	USD 9,121,344	USD 9,121,344	3,120	USD 209,736	USD 103.87	USD 105.22
2025-12-01 (Monday)	84,695	USD 8,911,608	USD 8,911,608	0	USD -271,024	USD 105.22	USD 108.42
2025-11-28 (Friday)	84,695	USD 9,182,632	USD 9,182,632	208	USD 75,778	USD 108.42	USD 107.79
2025-11-27 (Thursday)	84,487	USD 9,106,854	USD 9,106,854	0	USD 0	USD 107.79	USD 107.79
2025-11-26 (Wednesday)	84,487	USD 9,106,854	USD 9,106,854	624	USD -18,279	USD 107.79	USD 108.81
2025-11-25 (Tuesday)	83,863	USD 9,125,133	USD 9,125,133	1,040	USD -88,926	USD 108.81	USD 111.25
2025-11-24 (Monday)	82,823	USD 9,214,059	USD 9,214,059	208	USD 504,786	USD 111.25	USD 105.42
2025-11-21 (Friday)	82,615	USD 8,709,273	USD 8,709,273	0	USD 422,988	USD 105.42	USD 100.3
2025-11-20 (Thursday)	82,615	USD 8,286,285	USD 8,286,285	-832	USD -20,864	USD 100.3	USD 99.55
2025-11-19 (Wednesday)	83,447	USD 8,307,149	USD 8,307,149	208	USD 351,998	USD 99.55	USD 95.57
2025-11-18 (Tuesday)	83,239	USD 7,955,151	USD 7,955,151	1,248	USD 44,659	USD 95.57	USD 96.48
2025-11-17 (Monday)	81,991	USD 7,910,492	USD 7,910,492	416	USD 212,259	USD 96.48	USD 94.37

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GH by Blackrock for IE00BDZVHG35

Show aggregate share trades of GH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 3,120 107.436 103.360 103.768 USD 323,755 50.70
2025-11-28 BUY 208 108.810 106.480 106.713 USD 22,196 50.15
2025-11-26 BUY 624 109.810 106.670 106.984 USD 66,758 49.57
2025-11-26 BUY 624 109.810 106.670 106.984 USD 66,758 49.57
2025-11-25 BUY 1,040 111.900 108.530 108.867 USD 113,222 49.28
2025-11-24 BUY 208 111.911 104.350 105.106 USD 21,862 48.96
2025-11-20 SELL -832 110.000 100.035 101.032 USD -84,058 48.42 Loss of -43,775 on sale
2025-11-19 BUY 208 105.270 95.010 96.036 USD 19,975 48.16
2025-11-18 BUY 1,248 97.670 94.050 94.412 USD 117,826 47.91
2025-11-17 BUY 416 97.450 93.980 94.327 USD 39,240 47.66
2025-11-14 BUY 208 95.780 90.435 90.969 USD 18,922 47.42
2025-11-12 BUY 208 99.730 95.260 95.707 USD 19,907 46.91
2025-11-10 BUY 207 101.570 96.450 96.962 USD 20,071 46.37
2025-11-06 BUY 207 97.510 89.684 90.467 USD 18,727 45.84
2025-11-04 BUY 208 100.210 93.050 93.766 USD 19,503 45.29
2025-10-31 BUY 1,040 93.658 88.680 89.178 USD 92,745 44.74
2025-10-29 BUY 930 72.270 73.145 73.057 USD 67,943 44.32
2025-10-22 SELL -828 68.030 69.510 69.362 USD -57,432 43.59 Loss of -21,339 on sale
2025-10-20 BUY 414 70.200 70.280 70.272 USD 29,093 43.30
2025-10-17 BUY 1,034 65.460 67.100 66.936 USD 69,212 43.17
2025-10-15 BUY 1,648 64.190 65.270 65.162 USD 107,387 43.05
2025-10-03 BUY 1,435 62.840 63.610 63.533 USD 91,170 42.82
2025-10-02 BUY 205 61.460 63.000 62.846 USD 12,883 42.71
2025-09-30 BUY 410 62.480 62.550 62.543 USD 25,643 42.47
2025-09-26 BUY 410 60.030 60.710 60.642 USD 24,863 42.25
2025-09-25 BUY 410 60.180 63.050 62.763 USD 25,733 42.14
2025-09-18 BUY 213 58.800 58.920 58.908 USD 12,547 42.03
2025-09-17 BUY 642 57.190 58.750 58.594 USD 37,617 41.94
2025-09-11 SELL -214 56.800 58.040 57.916 USD -12,394 41.76 Loss of -3,457 on sale
2025-09-10 BUY 428 56.570 59.050 58.802 USD 25,167 41.67
2025-07-17 SELL -428 47.280 49.300 49.098 USD -21,014 41.46 Loss of -3,268 on sale
2025-07-16 BUY 721 47.810 48.990 48.872 USD 35,237 41.42
2025-07-11 SELL -1,696 50.250 51.500 51.375 USD -87,132 41.26 Loss of -17,148 on sale
2025-07-02 BUY 11,660 50.180 51.470 51.341 USD 598,636 41.01
2025-06-25 BUY 424 49.900 50.550 50.485 USD 21,406 40.73
2025-06-20 BUY 2,016 49.140 50.980 50.796 USD 102,405 40.55
2025-06-11 BUY 410 49.030 50.180 50.065 USD 20,527 40.08
2025-06-10 BUY 410 50.090 50.530 50.486 USD 20,699 40.00
2025-06-04 SELL -205 47.760 48.050 48.021 USD -9,844 39.74 Loss of -1,698 on sale
2025-04-23 BUY 205 45.640 47.710 47.503 USD 9,738 38.93
2025-04-10 SELL -1,640 41.140 42.440 42.310 USD -69,388 38.42 Loss of -6,382 on sale
2025-04-08 SELL -205 39.810 44.510 44.040 USD -9,028 38.34 Loss of -1,169 on sale
2025-04-07 SELL -205 41.780 43.330 43.175 USD -8,851 38.30 Loss of -999 on sale
2025-04-04 SELL -1,025 40.580 42.160 42.002 USD -43,052 38.27 Loss of -3,822 on sale
2025-04-01 BUY 1,792 42.470 43.110 43.046 USD 77,138 38.16
2025-03-31 SELL -606 42.600 43.260 43.194 USD -26,176 38.11 Loss of -3,084 on sale
2025-03-21 BUY 2,590 46.100 46.390 46.361 USD 120,075 37.52
2025-03-14 SELL -3,104 42.890 43.090 43.070 USD -133,689 37.05 Loss of -18,684 on sale
2025-03-07 SELL -388 39.320 40.500 40.382 USD -15,668 36.80 Loss of -1,388 on sale
2025-03-04 SELL -194 41.480 42.580 42.470 USD -8,239 36.58 Loss of -1,142 on sale
2025-02-25 BUY 388 40.350 44.010 43.644 USD 16,934 36.13
2025-02-19 SELL -193 49.000 49.500 49.450 USD -9,544 35.45 Loss of -2,703 on sale
2025-02-13 BUY 579 46.980 47.550 47.493 USD 27,498 34.45
2025-02-12 BUY 193 45.380 45.750 45.713 USD 8,823 34.23
2025-02-11 BUY 772 43.600 44.400 44.320 USD 34,215 34.03
2024-12-30 SELL -6,216 30.540 31.240 31.170 USD -193,753 29.04 Loss of -13,221 on sale
2024-11-18 SELL -3,150 28.960 29.740 29.662 USD -93,435 23.35 Loss of -19,883 on sale
2024-11-08 SELL -210 28.610 29.780 29.663 USD -6,229 22.52 Loss of -1,500 on sale
2024-10-21 SELL -211 20.840 21.480 21.416 USD -4,519 0.00 Loss of -4,519 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	3,120	107.436	103.360	103.768	USD 323,755	50.70
2025-11-28	BUY	208	108.810	106.480	106.713	USD 22,196	50.15
2025-11-26	BUY	624	109.810	106.670	106.984	USD 66,758	49.57
2025-11-26	BUY	624	109.810	106.670	106.984	USD 66,758	49.57
2025-11-25	BUY	1,040	111.900	108.530	108.867	USD 113,222	49.28
2025-11-24	BUY	208	111.911	104.350	105.106	USD 21,862	48.96
2025-11-20	SELL	-832	110.000	100.035	101.032	USD -84,058	48.42 Loss of -43,775 on sale
2025-11-19	BUY	208	105.270	95.010	96.036	USD 19,975	48.16
2025-11-18	BUY	1,248	97.670	94.050	94.412	USD 117,826	47.91
2025-11-17	BUY	416	97.450	93.980	94.327	USD 39,240	47.66
2025-11-14	BUY	208	95.780	90.435	90.969	USD 18,922	47.42
2025-11-12	BUY	208	99.730	95.260	95.707	USD 19,907	46.91
2025-11-10	BUY	207	101.570	96.450	96.962	USD 20,071	46.37
2025-11-06	BUY	207	97.510	89.684	90.467	USD 18,727	45.84
2025-11-04	BUY	208	100.210	93.050	93.766	USD 19,503	45.29
2025-10-31	BUY	1,040	93.658	88.680	89.178	USD 92,745	44.74
2025-10-29	BUY	930	72.270	73.145	73.057	USD 67,943	44.32
2025-10-22	SELL	-828	68.030	69.510	69.362	USD -57,432	43.59 Loss of -21,339 on sale
2025-10-20	BUY	414	70.200	70.280	70.272	USD 29,093	43.30
2025-10-17	BUY	1,034	65.460	67.100	66.936	USD 69,212	43.17
2025-10-15	BUY	1,648	64.190	65.270	65.162	USD 107,387	43.05
2025-10-03	BUY	1,435	62.840	63.610	63.533	USD 91,170	42.82
2025-10-02	BUY	205	61.460	63.000	62.846	USD 12,883	42.71
2025-09-30	BUY	410	62.480	62.550	62.543	USD 25,643	42.47
2025-09-26	BUY	410	60.030	60.710	60.642	USD 24,863	42.25
2025-09-25	BUY	410	60.180	63.050	62.763	USD 25,733	42.14
2025-09-18	BUY	213	58.800	58.920	58.908	USD 12,547	42.03
2025-09-17	BUY	642	57.190	58.750	58.594	USD 37,617	41.94
2025-09-11	SELL	-214	56.800	58.040	57.916	USD -12,394	41.76 Loss of -3,457 on sale
2025-09-10	BUY	428	56.570	59.050	58.802	USD 25,167	41.67
2025-07-17	SELL	-428	47.280	49.300	49.098	USD -21,014	41.46 Loss of -3,268 on sale
2025-07-16	BUY	721	47.810	48.990	48.872	USD 35,237	41.42
2025-07-11	SELL	-1,696	50.250	51.500	51.375	USD -87,132	41.26 Loss of -17,148 on sale
2025-07-02	BUY	11,660	50.180	51.470	51.341	USD 598,636	41.01
2025-06-25	BUY	424	49.900	50.550	50.485	USD 21,406	40.73
2025-06-20	BUY	2,016	49.140	50.980	50.796	USD 102,405	40.55
2025-06-11	BUY	410	49.030	50.180	50.065	USD 20,527	40.08
2025-06-10	BUY	410	50.090	50.530	50.486	USD 20,699	40.00
2025-06-04	SELL	-205	47.760	48.050	48.021	USD -9,844	39.74 Loss of -1,698 on sale
2025-04-23	BUY	205	45.640	47.710	47.503	USD 9,738	38.93
2025-04-10	SELL	-1,640	41.140	42.440	42.310	USD -69,388	38.42 Loss of -6,382 on sale
2025-04-08	SELL	-205	39.810	44.510	44.040	USD -9,028	38.34 Loss of -1,169 on sale
2025-04-07	SELL	-205	41.780	43.330	43.175	USD -8,851	38.30 Loss of -999 on sale
2025-04-04	SELL	-1,025	40.580	42.160	42.002	USD -43,052	38.27 Loss of -3,822 on sale
2025-04-01	BUY	1,792	42.470	43.110	43.046	USD 77,138	38.16
2025-03-31	SELL	-606	42.600	43.260	43.194	USD -26,176	38.11 Loss of -3,084 on sale
2025-03-21	BUY	2,590	46.100	46.390	46.361	USD 120,075	37.52
2025-03-14	SELL	-3,104	42.890	43.090	43.070	USD -133,689	37.05 Loss of -18,684 on sale
2025-03-07	SELL	-388	39.320	40.500	40.382	USD -15,668	36.80 Loss of -1,388 on sale
2025-03-04	SELL	-194	41.480	42.580	42.470	USD -8,239	36.58 Loss of -1,142 on sale
2025-02-25	BUY	388	40.350	44.010	43.644	USD 16,934	36.13
2025-02-19	SELL	-193	49.000	49.500	49.450	USD -9,544	35.45 Loss of -2,703 on sale
2025-02-13	BUY	579	46.980	47.550	47.493	USD 27,498	34.45
2025-02-12	BUY	193	45.380	45.750	45.713	USD 8,823	34.23
2025-02-11	BUY	772	43.600	44.400	44.320	USD 34,215	34.03
2024-12-30	SELL	-6,216	30.540	31.240	31.170	USD -193,753	29.04 Loss of -13,221 on sale
2024-11-18	SELL	-3,150	28.960	29.740	29.662	USD -93,435	23.35 Loss of -19,883 on sale
2024-11-08	SELL	-210	28.610	29.780	29.663	USD -6,229	22.52 Loss of -1,500 on sale
2024-10-21	SELL	-211	20.840	21.480	21.416	USD -4,519	0.00 Loss of -4,519 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	433,782	0	863,781	50.2%
2025-09-18	332,954	75	638,090	52.2%
2025-09-17	446,767	34	950,052	47.0%
2025-09-16	392,444	0	738,523	53.1%
2025-09-15	589,582	6,873	1,215,994	48.5%
2025-09-12	546,148	150	1,111,383	49.1%
2025-09-11	275,329	798	589,108	46.7%
2025-09-10	507,436	764	961,966	52.7%
2025-09-09	485,073	477	885,081	54.8%
2025-09-08	486,226	103	1,033,753	47.0%
2025-09-05	657,672	20,386	1,123,792	58.5%
2025-09-04	923,217	68,296	2,077,473	44.4%
2025-09-03	165,055	1,304	666,999	24.7%
2025-09-02	395,563	675	958,484	41.3%
2025-08-29	288,764	50	1,009,212	28.6%
2025-08-28	216,254	379	525,732	41.1%
2025-08-27	239,916	830	573,575	41.8%
2025-08-26	225,753	0	475,806	47.4%
2025-08-25	243,952	0	698,402	34.9%
2025-08-22	329,590	0	782,529	42.1%
2025-08-21	452,603	72	1,028,536	44.0%
2025-08-20	350,419	291	924,115	37.9%
2025-08-19	389,869	295	878,026	44.4%
2025-08-18	350,320	6	755,158	46.4%
2025-08-15	512,429	0	1,189,965	43.1%
2025-08-14	957,010	264	1,683,554	56.8%
2025-08-13	489,327	317	1,398,149	35.0%
2025-08-12	331,838	589	764,511	43.4%
2025-08-11	347,753	232	844,185	41.2%
2025-08-08	836,722	297	1,838,588	45.5%
2025-08-07	1,653,553	801	4,233,341	39.1%
2025-08-06	474,841	131	1,081,737	43.9%
2025-08-05	411,912	139	758,611	54.3%
2025-08-04	618,397	188	1,108,199	55.8%
2025-08-01	498,100	4,707	1,307,948	38.1%
2025-07-31	2,347,880	7,134	3,644,615	64.4%
2025-07-30	901,860	82	1,705,755	52.9%
2025-07-29	405,420	1,857	723,957	56.0%
2025-07-28	327,264	2,982	670,554	48.8%
2025-07-25	309,618	17	635,507	48.7%
2025-07-24	291,805	262	562,485	51.9%
2025-07-23	460,329	590	960,358	47.9%
2025-07-22	281,855	497	759,631	37.1%
2025-07-21	381,326	599	569,470	67.0%
2025-07-18	298,179	320	736,146	40.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE